SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-616646
Filing Date
2016-06-08
Accepted
2016-06-08 16:09:30
Documents
7
Effectiveness Date
2016-06-08

Document Format Files

Seq Description Document Type Size
1 NOTICE AND ACCESS d190941ddefa14a.htm DEFA14A 35318
2 GRAPHIC g190941naapg001a.jpg GRAPHIC 8794
3 GRAPHIC g190941naapg001b.jpg GRAPHIC 5482
4 GRAPHIC g190941naapg002a.jpg GRAPHIC 6946
5 GRAPHIC g190941naapg002b.jpg GRAPHIC 5541
6 GRAPHIC g190941naapg003.jpg GRAPHIC 5504
7 GRAPHIC g190941naapg004.jpg GRAPHIC 5483
  Complete submission text file 0001193125-16-616646.txt   88351
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36172 | Film No.: 161703666
SIC: 2836 Biological Products, (No Diagnostic Substances)